From the University of Illinois College of Medicine.
AMITA St. Joseph Transitional Year Program, Chicago, IL.
Dermatitis. 2020 Jul/Aug;31(4):247-258. doi: 10.1097/DER.0000000000000589.
: The role of Staphylococcus aureus (SA) in the pathogenesis and management in atopic dermatitis is rapidly evolving. The modern understanding of SA in atopic dermatitis now includes an expanded array of virulence factors, the interplay of clonal and temporal shifts in SA populations, and host factors such as filaggrin and natural moisturizing factor. New, emerging therapies that focus on long-term, targeted elimination of SA colonization are currently under investigation (Br J Dermatol 2017;17(1)63-71). Herein, we discuss and review the latest staphylococcal and microbiome-modifying therapies including topical antibiotics, topical natural oil fatty acids, anti-SA vaccines, microbial transplantation, vitamin D supplementation, dupilumab and proposed future investigative directions.
金黄色葡萄球菌(SA)在特应性皮炎发病机制和治疗中的作用正在迅速发展。目前对特应性皮炎中 SA 的认识包括一系列扩展的毒力因子、SA 群体克隆和时间变化的相互作用,以及宿主因素,如丝聚蛋白和天然保湿因子。目前正在研究新的、新兴的治疗方法,这些方法侧重于长期、有针对性地消除 SA 定植(英国皮肤病学杂志 2017 年;17(1)63-71)。本文讨论和回顾了最新的葡萄球菌和微生物组修饰疗法,包括局部抗生素、局部天然油脂肪酸、抗 SA 疫苗、微生物移植、维生素 D 补充剂、度普利尤单抗以及未来的研究方向。